Skip to content

Omnicell OMCL Inventories

Inventories at other companies

Baxter International logo
Baxter InternationalBAX
$2.32B+6.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3.36B-9.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$560.17M+5.0%
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
$47.16M+8.6%
Cardinal Health logo
Cardinal HealthCAH
$18.01B+11.4%
Cencora logo
CencoraCOR
$20.01B+5.5%

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's inventories?
Omnicell (OMCL) reported inventories of $99.2M in Q1 2026.
How has Omnicell's inventories changed year-over-year?
Omnicell's inventories increased by 8.8% year-over-year, from $91.14M to $99.2M.
What is the long-term trend for Omnicell's inventories?
Over 5 years (2020 to 2025), Omnicell's inventories has grown at a 0.9% compound annual growth rate (CAGR), from $96.3M to $100.91M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.